KRC/Y人腎癌細胞、KRC/
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/4/24 14:39:24
- 訪問次數(shù) 99
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
產(chǎn)品名稱: KRC/Y人腎癌細胞、 KRC/Y人腎癌細胞、 KRC/Y人腎癌細胞、 KRC/Y人腎癌細胞;
significant differences in the level of expression of each of these genes between patient risk groups.
Conclusion: Overall, our data suggest that hypoxia is associated with the prognosis and rate of immune cell infiltration in patients with colorectal cancer. This finding may improve immunotherapy for colorectal cancer.The discovery of tumor immune checkpoints provides a new idea for tumor immunotherapy. New immune